1. Home
  2. LUD vs ALEC Comparison

LUD vs ALEC Comparison

Compare LUD & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUD
  • ALEC
  • Stock Information
  • Founded
  • LUD 2004
  • ALEC 2013
  • Country
  • LUD Hong Kong
  • ALEC United States
  • Employees
  • LUD N/A
  • ALEC N/A
  • Industry
  • LUD
  • ALEC Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LUD
  • ALEC Health Care
  • Exchange
  • LUD NYSE
  • ALEC Nasdaq
  • Market Cap
  • LUD 96.7M
  • ALEC 101.1M
  • IPO Year
  • LUD 2025
  • ALEC 2019
  • Fundamental
  • Price
  • LUD $4.00
  • ALEC $1.17
  • Analyst Decision
  • LUD
  • ALEC Buy
  • Analyst Count
  • LUD 0
  • ALEC 7
  • Target Price
  • LUD N/A
  • ALEC $4.70
  • AVG Volume (30 Days)
  • LUD 9.6K
  • ALEC 960.4K
  • Earning Date
  • LUD 01-01-0001
  • ALEC 05-08-2025
  • Dividend Yield
  • LUD N/A
  • ALEC N/A
  • EPS Growth
  • LUD N/A
  • ALEC N/A
  • EPS
  • LUD N/A
  • ALEC N/A
  • Revenue
  • LUD $44,863,430.00
  • ALEC $88,339,000.00
  • Revenue This Year
  • LUD N/A
  • ALEC N/A
  • Revenue Next Year
  • LUD N/A
  • ALEC $376.51
  • P/E Ratio
  • LUD N/A
  • ALEC N/A
  • Revenue Growth
  • LUD N/A
  • ALEC N/A
  • 52 Week Low
  • LUD $3.40
  • ALEC $0.87
  • 52 Week High
  • LUD $5.43
  • ALEC $6.78
  • Technical
  • Relative Strength Index (RSI)
  • LUD N/A
  • ALEC 51.49
  • Support Level
  • LUD N/A
  • ALEC $0.97
  • Resistance Level
  • LUD N/A
  • ALEC $1.34
  • Average True Range (ATR)
  • LUD 0.00
  • ALEC 0.11
  • MACD
  • LUD 0.00
  • ALEC 0.01
  • Stochastic Oscillator
  • LUD 0.00
  • ALEC 53.68

About LUD LUDA TECHNOLOGY GROUP LIMITED

Luda Technology Group Ltd is a company that is principally engaged in the manufacture and sale of stainless steel and carbon steel flanges and fittings products and trading of steel pipes, valves, and other steel tubing products.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Share on Social Networks: